News By Tag Industry News News By Location Country(s) Industry News
| NuSep releases ProteoIQ 2.0: Quantitatively Superior with Biological SignificanceProteoIQ 2.0 provides researchers with a unified software solution for the major proteomic quantification strategies and adds tools for distilling biological meaning from high-throughput proteomic data in a manner that was not previously possible.
By: Ron Orlando “ProteoIQ has fundamentally changed how we process, interpret, and share data within our lab and between collaborators. The software has become an indispensable tool in our proteomics workflows and the technical support from NuSep is second to none. Outstanding product!” stated David Muddiman and Adam Hawkridge, from the W.M. Keck FT-ICR Mass Spectrometry Laboratory, NC State University. ProteoIQ has always been known as an innovative and time-saving bioinformatics tool for the analysis of proteomic data. The new functionality included in ProteoIQ 2.0 is specifically designed to extend the bioinformatic pipe-line from quantification to biological discovery. With the introduction of the metabolic labeling (SILAC) module, which can also be used for any isotopic labeling strategy that alters the precursor mass, such as ICAT and 18O labeling, ProteoIQ 2.0 supports the major proteomic quantification strategies. In addition, the integrated statistical analysis of variance (ANOVA), assessments of reproducibility, and point-and-click normalization functions offered by ProteoIQ 2.0 improve the confidence in identifying changes in protein expression. Jeremiah D. Tipton from the National High Magnetic Field Laboratory, Florida State University said “Comparison and extraction of relevant data is quick and simple with correct use of the statistical models.” ProteoIQ 2.0 is a unique single software solution for label-free, isobaric tag, and isotopic labeling proteomic strategies. ProteoIQ 2.0 also allows researchers to quickly move from high-throughput experimental data to the discovery of novel biological insights by combining proteomic results with any user-defined biological annotation. A few simple mouse clicks allows one to display protein abundance along pathways, or compare proteomic data to transcriptome data, such as microarray and/or rt-PCR, thus quickly shifting the focus to discovering the results most relevant to the experimental system. ProteoIQ 2.0 will be exhibited at the 2010 American Society for Mass Spectrometry Conference (ASMS), May 23-27, 2010 in Salt Lake City, UT and will soon be available to the general public at www.bioinquire.com. About NuSep NuSep is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep recently acquired BioInquire which developed the ProteoIQ software enabling NuSep to offer a total Proteomics solution from Fraction to Function. The company has offices in both Sydney Australia and Atlanta, USA. With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification. NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia. NuSep Products: Gels – NuSep manufactures and sells precast gels including the innovative NUView Gels, which can be visualised 2 minutes after use. Separation Instruments – NuSep has developed two unique biological separation instruments. The ProteomeSep was released in 2008 and can separate biological samples into 8 fractions for use in the proteomic market. The SpermSep separates sperm for fertility treatments such as IVF and is expected to undergoing clinical trials later this year. Proteomics Software – NuSep offers the unique ProteoIQ software for the analysis of complex mass spec samples. This software is also designed to identify bio markers. Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin. For more information about NuSep please visit the company’s website www.NuSep.com Australian Contact: Prakash Patel Chief Financial Officer & Company Secretary +61 2 8197 3377 Prakash.patel@ US Contact: James A. Atwood VP Sales Phone: 706/583-4000 or 888/291-2246 jatwood@bioinquire.com # # # NuSep is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep recently acquired BioInquire which developed the ProteoIQ software enabling NuSep to offer a total Proteomics solution from Fraction to Function. The company has offices in both Sydney Australia and Atlanta, USA. With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification. NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
